Market Overview:
The global immunosuppressant TDM assay kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of organ transplantations, rising demand for personalized medicine, and technological advancements in immunosuppressant TDM assay kits. Based on type, the global immunosuppressant TDM assay kit market is segmented into high performance liquid chromatography (HPLC), fluorescence polarization immunoassay (FPIA), radioimmunoassay (RIA), homogeneous enzyme immunoassay (HIEA), and dry spot analysis. HPLC is expected to account for the largest share of the global Immunosuppressants TDM Assay Kit Market by type during the forecast period. This can be attributed to its ability to provide accurate and reproducible results with high sensitivity and specificity. Based on application, the hospital segment is expected to account for the largest share of the global Immunosuppressants TDM Assay Kit Market duringthe forecast period. This can be attributedto th e growing demand for personalized medicineand increasing incidenceof organ transplantations worldwide . The academic and research institute segmentis projectedt o witnessthe highest CAGRduringthe forecastperiod .
Product Definition:
The Immunosuppressant TDM Assay Kit is a test used to determine the levels of immunosuppressive drugs in a patient's blood. The kit can help doctors to adjust the dosage of medication as needed in order to maintain the desired level of suppression.
High Performance Liquid Chromatography:
High performance liquid chromatography (HPLC) is a separation method that involves the use of a solvent to dissolve the compounds in question and then run them through an HPLC device. The compounds are separated based on their molecular weight, size, ionic strength or any other property that helps in their identification.
The major advantage of this technique is its ability to separate chiral molecules.
Fluorescence Polarization Immunoassay:
Fluorescence Polarization Immunoassay (FPIA) is a technique used for the detection of specific antibodies in biological fluids. It utilizes fluorescence polarization process to separate an optical component that is involved in light absorption and re-emission by the fluorescent probes. The separation takes place between two electrodes placed in a fluid solution, wherein one electrode is situated at the liquid surface and other at the air interface.
Application Insights:
The hospital application segment dominated the global immunosuppressant TDM assay kit market in 2017. This can be attributed to factors such as an increase in the number of patients with multiple sclerosis and other autoimmune diseases, which is resulting in a growing demand for immunosuppressants. In addition, an increase in R&D activities pertaining to new drug development for various autoimmune diseases is further driving the growth of this segment.
For instance, according to data published by National Institute of Health (NIH), around 300-400 new drugs are developed every year worldwide; out of which only 2% reach the phase III clinical trials and less than 5% get approved by U.S FDA/European Commission (EC) after extensive clinical testing. Therefore, increasing incidence rate and research & development activities related to immunology are expected to augment product demand over the forecast period from 2018 - 2030 globally.
Regional Analysis:
North America dominated the global immunosuppressant TDM assay kit market in 2017. The presence of sophisticated healthcare infrastructure, high adoption rate of new technologies, and increasing focus on drug development for chronic diseases are some factors responsible for its large share. In addition, the growing number of clinical trials conducted to test new drugs for treating autoimmune disorders is expected to drive demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in government initiatives aimed at improving access rates has led to a rise in demand from remote areas resulting into higher regional revenue generation capacity than developed regions like North America or Europe.
Growth Factors:
- Increasing incidence of organ transplantation surgeries across the globe is expected to drive the demand for Immunosuppressant TDM Assay Kit market over the forecast period.
- Growing awareness about benefits of early diagnosis and treatment is anticipated to propel the growth of Immunosuppressant TDM Assay Kit market in near future.
- Rising number of research and development activities for novel immunosuppressive drugs is projected to fuel the demand for Immunosuppressant TDM Assay Kit products over the forecast period.
- Technological advancements in assay kits are likely to create new opportunities for players operating in Immunosuppressant TDM Assay Kit market during forecast period. 5) increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is expected to boost demand for immunosuppressive drugs, which will subsequently drive growth of Immunosuppressant TDM Assay kit market over next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunosuppressant TDM Assay Kit Market Research Report
By Type
High Performance Liquid Chromatography, Fluorescence Polarization Immunoassay, Radioimmunoassay, Homogenous Enzyme Immunoassay, Dry Spot Analysis
By Application
Hospital, Academic and Research Institute, Contract Research Organization, Biopharmaceutical Company
By Companies
Waters, Thermo Fisher Scientific, Recipe Chemicals, Zivak Technologies USA, Abbott, Aurora Borealis Control BV
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Immunosuppressant TDM Assay Kit Market Report Segments:
The global Immunosuppressant TDM Assay Kit market is segmented on the basis of:
Types
High Performance Liquid Chromatography, Fluorescence Polarization Immunoassay, Radioimmunoassay, Homogenous Enzyme Immunoassay, Dry Spot Analysis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Academic and Research Institute, Contract Research Organization, Biopharmaceutical Company
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Waters
- Thermo Fisher Scientific
- Recipe Chemicals
- Zivak Technologies USA
- Abbott
- Aurora Borealis Control BV
Highlights of The Immunosuppressant TDM Assay Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- High Performance Liquid Chromatography
- Fluorescence Polarization Immunoassay
- Radioimmunoassay
- Homogenous Enzyme Immunoassay
- Dry Spot Analysis
- By Application:
- Hospital
- Academic and Research Institute
- Contract Research Organization
- Biopharmaceutical Company
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunosuppressant TDM Assay Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Immunosuppressant TDM Assay Kit is a diagnostic tool that can be used to measure the levels of immunosuppressive drugs in a patient's blood. This kit allows for the detection of various types of immunosuppressive drugs, including corticosteroids, cyclophosphamide, and methotrexate.
Some of the major players in the immunosuppressant tdm assay kit market are Waters, Thermo Fisher Scientific, Recipe Chemicals, Zivak Technologies USA, Abbott, Aurora Borealis Control BV.
The immunosuppressant tdm assay kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunosuppressant TDM Assay Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunosuppressant TDM Assay Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunosuppressant TDM Assay Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunosuppressant TDM Assay Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunosuppressant TDM Assay Kit Market Size & Forecast, 2018-2028
4.5.1 Immunosuppressant TDM Assay Kit Market Size and Y-o-Y Growth
4.5.2 Immunosuppressant TDM Assay Kit Market Absolute $ Opportunity
Chapter 5 Global Immunosuppressant TDM Assay Kit Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Immunosuppressant TDM Assay Kit Market Size Forecast by Type
5.2.1 High Performance Liquid Chromatography
5.2.2 Fluorescence Polarization Immunoassay
5.2.3 Radioimmunoassay
5.2.4 Homogenous Enzyme Immunoassay
5.2.5 Dry Spot Analysis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Immunosuppressant TDM Assay Kit Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Immunosuppressant TDM Assay Kit Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Academic and Research Institute
6.2.3 Contract Research Organization
6.2.4 Biopharmaceutical Company
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immunosuppressant TDM Assay Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunosuppressant TDM Assay Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunosuppressant TDM Assay Kit Analysis and Forecast
9.1 Introduction
9.2 North America Immunosuppressant TDM Assay Kit Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunosuppressant TDM Assay Kit Market Size Forecast by Type
9.6.1 High Performance Liquid Chromatography
9.6.2 Fluorescence Polarization Immunoassay
9.6.3 Radioimmunoassay
9.6.4 Homogenous Enzyme Immunoassay
9.6.5 Dry Spot Analysis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Immunosuppressant TDM Assay Kit Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Academic and Research Institute
9.10.3 Contract Research Organization
9.10.4 Biopharmaceutical Company
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Immunosuppressant TDM Assay Kit Analysis and Forecast
10.1 Introduction
10.2 Europe Immunosuppressant TDM Assay Kit Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunosuppressant TDM Assay Kit Market Size Forecast by Type
10.6.1 High Performance Liquid Chromatography
10.6.2 Fluorescence Polarization Immunoassay
10.6.3 Radioimmunoassay
10.6.4 Homogenous Enzyme Immunoassay
10.6.5 Dry Spot Analysis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Immunosuppressant TDM Assay Kit Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Academic and Research Institute
10.10.3 Contract Research Organization
10.10.4 Biopharmaceutical Company
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Immunosuppressant TDM Assay Kit Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunosuppressant TDM Assay Kit Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunosuppressant TDM Assay Kit Market Size Forecast by Type
11.6.1 High Performance Liquid Chromatography
11.6.2 Fluorescence Polarization Immunoassay
11.6.3 Radioimmunoassay
11.6.4 Homogenous Enzyme Immunoassay
11.6.5 Dry Spot Analysis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Immunosuppressant TDM Assay Kit Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Academic and Research Institute
11.10.3 Contract Research Organization
11.10.4 Biopharmaceutical Company
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Immunosuppressant TDM Assay Kit Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunosuppressant TDM Assay Kit Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunosuppressant TDM Assay Kit Market Size Forecast by Type
12.6.1 High Performance Liquid Chromatography
12.6.2 Fluorescence Polarization Immunoassay
12.6.3 Radioimmunoassay
12.6.4 Homogenous Enzyme Immunoassay
12.6.5 Dry Spot Analysis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Immunosuppressant TDM Assay Kit Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Academic and Research Institute
12.10.3 Contract Research Organization
12.10.4 Biopharmaceutical Company
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Immunosuppressant TDM Assay Kit Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunosuppressant TDM Assay Kit Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunosuppressant TDM Assay Kit Market Size Forecast by Type
13.6.1 High Performance Liquid Chromatography
13.6.2 Fluorescence Polarization Immunoassay
13.6.3 Radioimmunoassay
13.6.4 Homogenous Enzyme Immunoassay
13.6.5 Dry Spot Analysis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Immunosuppressant TDM Assay Kit Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Academic and Research Institute
13.10.3 Contract Research Organization
13.10.4 Biopharmaceutical Company
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immunosuppressant TDM Assay Kit Market: Competitive Dashboard
14.2 Global Immunosuppressant TDM Assay Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Waters
14.3.2 Thermo Fisher Scientific
14.3.3 Recipe Chemicals
14.3.4 Zivak Technologies USA
14.3.5 Abbott
14.3.6 Aurora Borealis Control BV
